Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Pierre Fabre Dermatologie represented by Institut de Recherche Pierre Fabre
Woman and Man Max 99 years
Pierre Fabre Dermatologie represented by Institut de Recherche Pierre Fabre
Update Il y a 4 ans
Efficacy of topic RV3131A-HC3221 in the prevention of polymorphic light eruption
The evaluation of the efficacy of the sunscreen RV 3131 A HC 3221 on the prevention of Polymorphic Light Eruption among subjects having PMLE history and for whom the diagnosis will be confirmed by a p...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pierre Fabre Dermatologie represented by Institut de Recherche Pierre Fabre
Update Il y a 4 ans
Assessment of the activity of a new cream containing betamethasone dipropionate at 0.010%, 0.025% and 0.050% versus reference products using a vasoconstriction assay in healthy subjects
This study is a pharmacodynamic study based on the corticosteroid induced skin vasoconstriction in healthy human skin. The main objective is to determine the place of new betamethasone dipropionate cr...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Pierre Fabre Dermatologie represented by Institut de Recherche Pierre Fabre
Update Il y a 4 ans
EFFICACY AND SAFETY OF 8% CLOBETASOL NAIL LACQUER FORMULATION VERSUS VEHICLE IN NAIL PSORIASIS
Main objective : To assess the efficacy of a 6-month daily application of 8% clobetasol nail lacquer versus vehicle in fingernail psoriasis using: · The dynamic Physician (blinded expert) Global Asse...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Pierre Fabre Dermatologie represented by Institut de Recherche Pierre Fabre
Update Il y a 4 ans
Efficacy and safety of 0,1%, 0,5% and 1% TAZAROTENE nail lacquer formulation versus vehicle in nail psoriasis. International, multicenter, double-blind, randomized study of four parallel groups
To assess the efficacy of a 6-month daily application of 0.1% , 0.5% and 1% tazarotene fingernail lacquer in fingernail psoriasis, using Expert Physician Global Assessment (EPGA) corresponding to a bl...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pierre Fabre Dermatologie represented by Institut de Recherche Pierre Fabre
Update Il y a 4 ans
Study in infants with infantile hemangioma to compare propranolol gel to placebo. Estudio en lactantes con hemangioma infantil para comparar propranolol gel con placebo
To assess propranolol gel efficacy in terms of complete/nearly complete resolution of the Infantile Hemangioma at W12 compared to baseline. Analizar la eficacia de propranolol gel, expresada com...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Pierre Fabre Dermatologie represented by Institut de Recherche Pierre Fabre
Update Il y a 4 ans
NON-INFERIORITY STUDY OF A METRONIDAZOLE 0.75% CREAM VERSUS REFERENCE THERAPY IN THE LOCAL TREATMENT OF PAPULOPUSTULAR ROSACEA
To assess the non-inferiority of a metronidazole 0.75% cream (Rosiced) in comparison to reference therapy (Rozex) in the local treatment of papulopustular rosacea
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pierre Fabre Dermatologie represented by Institut de Recherche Pierre Fabre
Update Il y a 4 ans
EFFICACY STUDY OF A CICLOPIROXOLAMINE 1% FOAM (DC115 GM 02A) VERSUS CICLOPIROXOLAMINE 1.5% SHAMPOO (SEBIPROX®) IN THE TREATMENT OF MODERATE SEBORRHEIC DERMATITIS OF THE SCALP
To assess the efficacy of a ciclopiroxolamine 1% foam (DC115 GM 02A) versus reference therapy ciclopiroxolamine 1.5% shampoo (SEBIPROX®), on moderate seborrheic dermatitis of the scalp, after 4 weeks ...
Country
None
organs
None
Specialty
None
unknown
More information